Literature DB >> 17940118

Insulin resistance of protein metabolism in type 2 diabetes.

Sandra Pereira1, Errol B Marliss, José A Morais, Stéphanie Chevalier, Réjeanne Gougeon.   

Abstract

OBJECTIVE: We previously demonstrated that 1) obesity impairs and 2) sex influences insulin sensitivity of protein metabolism, while 3) poor glycemic control in type 2 diabetes accelerates protein turnover in daily fed-fasted states. We hypothesized that type 2 diabetes alters the insulin sensitivity of protein metabolism and that sex modulates it. RESEARCH DESIGN AND METHODS: Hyperinsulinemic ( approximately 570 pmol/l), euglycemic (5.5 mmol/l), and isoaminoacidemic (kept at postabsorptive concentrations) clamps were performed in 17 hyperglycemic type 2 diabetic subjects and 23 subjects without diabetes matched for age and body composition, after 7 days on a inpatient, protein-controlled, isoenergetic diet. Glucose and leucine kinetics were determined using tracers.
RESULTS: In type 2 diabetes, postabsorptive (baseline) glycemia was 8-9 mmol/l, glucose production (R(a)) and disposal (R(d)) were elevated, and once clamped, endogenous glucose R(a) remained greater and R(d) was less (P < 0.05) than in control subjects. Baseline leucine kinetics did not differ despite higher insulin levels. The latter was an independent predictor of leucine flux within each sex. With clamp, total flux increased less (P = 0.016) in type 2 diabetic men, although protein breakdown decreased equally ( approximately 20%) in male groups but less in female groups. Whereas protein synthesis increased in male control subjects and in both female groups, it did not in male subjects with type 2 diabetes. In men, homeostasis model assessment of insulin resistance predicted 44%, and, in women, waist-to-hip ratio predicted 40% of the change in synthesis.
CONCLUSIONS: During our clamp, men with type 2 diabetes have greater insulin resistance of protein metabolism than that conferred by excess adiposity itself, whereas women do not. These results may have implications for dietary protein requirements.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940118     DOI: 10.2337/db07-0887

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  58 in total

1.  Plasma metabolomic profile in nonalcoholic fatty liver disease.

Authors:  Satish C Kalhan; Lining Guo; John Edmison; Srinivasan Dasarathy; Arthur J McCullough; Richard W Hanson; Mike Milburn
Journal:  Metabolism       Date:  2010-04-27       Impact factor: 8.694

Review 2.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

3.  Effects of type 2 diabetes and insulin on whole-body, splanchnic, and leg protein metabolism.

Authors:  Kevin R Short; Brian A Irving; Ananda Basu; C Michael Johnson; K Sreekumaran Nair; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2012-10-02       Impact factor: 5.958

4.  Age attenuates leucine oxidation after eccentric exercise.

Authors:  E L Kullman; W W Campbell; R K Krishnan; K E Yarasheski; W J Evans; J P Kirwan
Journal:  Int J Sports Med       Date:  2013-01-16       Impact factor: 3.118

5.  Fed-state clamp stimulates cellular mechanisms of muscle protein anabolism and modulates glucose disposal in normal men.

Authors:  Olasunkanmi A J Adegoke; Stéphanie Chevalier; José A Morais; Réjeanne Gougeon; Scot R Kimball; Leonard S Jefferson; Simon S Wing; Errol B Marliss
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-28       Impact factor: 4.310

6.  Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.

Authors:  R Malhotra; K L Cavanaugh; W J Blot; T A Ikizler; L Lipworth; E K Kabagambe
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-07-21       Impact factor: 4.222

7.  Metabolic changes in serum metabolome in response to a meal.

Authors:  Aahana Shrestha; Elisabeth Müllner; Kaisa Poutanen; Hannu Mykkänen; Ali A Moazzami
Journal:  Eur J Nutr       Date:  2015-12-10       Impact factor: 5.614

8.  The 2010 ESPEN Sir David Cuthbertson Lecture: new and old proteins: clinical implications.

Authors:  Rozalina G McCoy; K Sreekumaran Nair
Journal:  Clin Nutr       Date:  2013-01-18       Impact factor: 7.324

9.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.

Authors:  Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

10.  Excessive loss of skeletal muscle mass in older adults with type 2 diabetes.

Authors:  Seok Won Park; Bret H Goodpaster; Jung Sun Lee; Lewis H Kuller; Robert Boudreau; Nathalie de Rekeneire; Tamara B Harris; Stephen Kritchevsky; Frances A Tylavsky; Michael Nevitt; Yong-wook Cho; Anne B Newman
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.